307 related articles for article (PubMed ID: 29408822)
1. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
[TBL] [Abstract][Full Text] [Related]
2. Determination of EPAC2 function using EPAC2 null Min6 sublines generated through CRISPR-Cas9 technology.
Xu H; Yang Y; Chen Y; Mueller U; Iyer S; Presland J; Yang R; Kariv I
Mol Cell Endocrinol; 2018 Sep; 473():114-123. PubMed ID: 29407196
[TBL] [Abstract][Full Text] [Related]
3. GPRC5B a putative glutamate-receptor candidate is negative modulator of insulin secretion.
Soni A; Amisten S; Rorsman P; Salehi A
Biochem Biophys Res Commun; 2013 Nov; 441(3):643-8. PubMed ID: 24404583
[TBL] [Abstract][Full Text] [Related]
4. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
Farooq R; Hussain K; Nazir S; Javed MR; Masood N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
[TBL] [Abstract][Full Text] [Related]
7. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
8. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
9. An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system.
Niccheri F; Pecori R; Conticello SG
Cell Mol Life Sci; 2017 Sep; 74(18):3413-3423. PubMed ID: 28421278
[TBL] [Abstract][Full Text] [Related]
10. The Axis of CXCR4/SDF-1 Plays a Role in Colon Cancer Cell Adhesion Through Regulation of the AKT and IGF1R Signalling Pathways.
Zheng F; Zhang Z; Flamini V; Jiang WG; Cui Y
Anticancer Res; 2017 Aug; 37(8):4361-4369. PubMed ID: 28739729
[TBL] [Abstract][Full Text] [Related]
11. SNAP-tag-enabled super-resolution imaging reveals constitutive and agonist-dependent trafficking of GPR56 in pancreatic β-cells.
Olaniru OE; Cheng J; Ast J; Arvaniti A; Atanes P; Huang GC; King AJF; Jones PM; Broichhagen J; Hodson DJ; Persaud SJ
Mol Metab; 2021 Nov; 53():101285. PubMed ID: 34224919
[TBL] [Abstract][Full Text] [Related]
12. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
[TBL] [Abstract][Full Text] [Related]
14. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium.
Pyne ME; Bruder MR; Moo-Young M; Chung DA; Chou CP
Sci Rep; 2016 May; 6():25666. PubMed ID: 27157668
[TBL] [Abstract][Full Text] [Related]
15. Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRISPR/Cas9 System.
Wolf T; Gren T; Thieme E; Wibberg D; Zemke T; Pühler A; Kalinowski J
J Biotechnol; 2016 Aug; 231():122-128. PubMed ID: 27262504
[TBL] [Abstract][Full Text] [Related]
16. Speed genome editing by transient CRISPR/Cas9 targeting and large DNA fragment deletion.
Luo J; Lu L; Gu Y; Huang R; Gui L; Li S; Qi X; Zheng W; Chao T; Zheng Q; Liang Y; Zhang L
J Biotechnol; 2018 Sep; 281():11-20. PubMed ID: 29886029
[TBL] [Abstract][Full Text] [Related]
17. Rapid and efficient generation of GFP-knocked-in Drosophila by the CRISPR-Cas9-mediated genome editing.
Kina H; Yoshitani T; Hanyu-Nakamura K; Nakamura A
Dev Growth Differ; 2019 May; 61(4):265-275. PubMed ID: 31037730
[TBL] [Abstract][Full Text] [Related]
18. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
Millette K; Georgia S
Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
[TBL] [Abstract][Full Text] [Related]
19. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
[TBL] [Abstract][Full Text] [Related]
20. [Knocking-out of HIF1α gene by CRISPR/cas9 inhibits proliferation and invasiveness of prostate cancer DU145 cells].
Xu Y; Xu M; Zhang M; Tan J; Su Z; Chen X; Zhou Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):160-164. PubMed ID: 29652983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
